Free Trial
→ Trump’s Exec Order #14154 could be a “Millionaire-Maker” (From Paradigm Press) (Ad) Free IMRX Stock Alerts

Immuneering (IMRX) Insider Trading & Ownership

Immuneering logo
$4.42 +0.09 (+2.08%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$4.36 -0.05 (-1.24%)
As of 07/11/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Immuneering (NASDAQ:IMRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.90%
Number Of
Insiders Buying
(Last 12 Months)
7
Amount Of
Insider Buying
(Last 12 Months)
$334.32K
Number Of
Insiders Selling
(Last 12 Months)
0
Get IMRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immuneering stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IMRX Insider Buying and Selling by Quarter

Immuneering Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/2/2025Benjamin J ZeskindCEOBuy7,015$3.53$24,762.95  
7/2/2025Diana HausmanDirectorBuy2,500$3.60$9,000.00  
7/2/2025Diana HausmanDirectorBuy3,000$3.62$10,860.00  
7/2/2025Leah R NeufeldInsiderBuy700$3.57$2,499.00  
7/1/2025Benjamin J ZeskindCEOBuy2,985$3.38$10,089.30  
6/27/2025Thomas J SchallDirectorBuy9,500$3.66$34,770.00  
6/23/2025Brett Matthew HallInsiderBuy6,007$2.43$14,597.01  
6/20/2025Brett Matthew HallInsiderBuy7,415$2.70$20,020.50  
6/20/2025Harold Eugene BrakewoodInsiderBuy1,900$2.53$4,807.00  
6/18/2025Benjamin J ZeskindCEOBuy21,000$2.39$50,190.00  
6/18/2025Peter FeinbergDirectorBuy25,000$2.53$63,250.00  
6/17/2025Thomas J SchallDirectorBuy40,485$2.21$89,471.85  
(Data available from 1/1/2013 forward)

IMRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Immuneering includes Ann E Berman, Benjamin J Zeskind, Brett Matthew Hall, Cormorant Asset Management, Lp, Diana Hausman, Harold Eugene Brakewood, Leah R Neufeld, Mallory Morales, Peter Feinberg, and Thomas J Schall. Learn more on insiders at IMRX.

22.90% of Immuneering stock is owned by insiders. Learn more on IMRX's insider holdings.

The following insiders have purchased IMRX shares in the last 24 months: Ann E Berman ($123,465.45), Benjamin J Zeskind ($140,442.25), Brett Matthew Hall ($34,617.51), Diana Hausman ($19,860.00), Harold Eugene Brakewood ($14,830.00), Leah R Neufeld ($13,494.84), Mallory Morales ($3,011.04), Peter Feinberg ($127,000.00), and Thomas J Schall ($124,241.85).

Insiders have purchased a total of 239,297 IMRX shares in the last 24 months for a total of $600,962.94 bought.

The following insider sold IMRX shares in the last 24 months: Cormorant Asset Management, Lp ($3,053,818.52).

Insiders have sold a total of 909,091 Immuneering shares in the last 24 months for a total of $3,053,818.52 sold.

Immuneering Key Executives

  • Dr. Benjamin J. Zeskind M.B.A. (Age 41)
    Ph.D., Co-Founder, President, CEO & Director
    Compensation: $935.09k
  • Mr. Robert J. Carpenter M.B.A. (Age 78)
    M.S., Co-Founder & Chair Emeritus
    Compensation: $75.36k
  • Dr. Brett M. Hall Ph.D. (Age 55)
    Chief Scientific Officer
    Compensation: $905.41k
  • Mr. Harold E. Brakewood (Age 58)
    Chief Business Officer
    Compensation: $579.77k
    1 recent trades
  • Ms. Mallory Morales CPA (Age 40)
    Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer
  • Ms. Paula George CPA
    Director of Accounting & Operations and Assistant Corporate Controller
  • Mr. Michael D. Bookman J.D. (Age 37)
    Chief Legal Officer & Secretary
  • Ms. Leah R. Neufeld (Age 51)
    Chief People Officer
    1 recent trades
  • Dr. Peter King Ph.D.
    Head of Discovery & VP
  • Dr. Praveen Nair Ph.D.
    Head of Translational Pharmacology & VP

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:IMRX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored